StockMarketWire.com - Animalcare Group has added two new products to its range of licensed pharmaceuticals.

This follows approval from the Veterinary Medicines Directorate and the Irish Medicines Board on 27 April.

The new products, Sedastart and Sedastop, complement Animalcare's existing range of analgesia and anaesthesia products to provide a more complete product suite and can be used alongside Buprecare, the group's leading analgesic used on dogs and cats.

The launch of Sedastart and Sedastop follows the successful launches of Cephacare, Buprecare and Benazecare in the UK and on mainland Europe.

The net turnover for the target markets of Sedastart and Sedastop is approximately £1.0m in each segment.






Story provided by StockMarketWire.com